2026. Curative Conversion of Metastatic Gastric Cancer After Pembrolizumab-Trastuzumab-Based Therapy in a PD-L1-Negative, HER2-Positive Patient: A Case Report and Literature Review. MENA Journal of Case Reports. 1, 1 (May 2026), 30–38. DOI:https://doi.org/10.64913/mmrmjcr.v1i1.21.